# BMI Effect on the Response to Ovulation Induction in Letrozole vs Clomid

> **NCT04331197** · PHASE4 · UNKNOWN · sponsor: **Cairo University** · enrollment: 160 (estimated)

## Conditions studied

- Subfertility

## Interventions

- **DRUG:** Clomiphene Citrate 50mg
- **DRUG:** Letrozole 2.5mg

## Key facts

- **NCT ID:** NCT04331197
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04331197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04331197, "BMI Effect on the Response to Ovulation Induction in Letrozole vs Clomid". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04331197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*